• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吡咯并吡啶酮衍生物作为 Cdc7 的抗癌抑制剂:基于溶剂化能评分方法对接的定量构效关系研究。

Novel pyrrolopyridinone derivatives as anticancer inhibitors towards Cdc7: QSAR studies based on dockings by solvation score approach.

机构信息

Pharmacy College, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China.

出版信息

Eur J Pharm Sci. 2013 Nov 20;50(3-4):323-34. doi: 10.1016/j.ejps.2013.07.013. Epub 2013 Aug 8.

DOI:10.1016/j.ejps.2013.07.013
PMID:23933111
Abstract

A series of pyrrolopyridinone derivatives as specific inhibitors towards the cell division cycle 7 (Cdc7) was taken into account, and the efficacy of these compounds was analyzed by QSAR and docking approaches to gain deeper insights into the interaction mechanism and ligands selectivity for Cdc7. By regression analysis the prediction models based on Grid score and Zou-GB/SA score were found, respectively with good quality of fits (r(2)=0.748, 0.951; r(cv)(2)=0.712, 0.839). The accuracy of the models was validated by test set and the deviation of the predicted values in validation set using Zou-GB/SA score was smaller than that using Grid score, suggesting that the model based on Zou-GB/SA score provides a more effective method for predicting potencies of Cdc7 inhibitors.

摘要

考虑了一系列作为细胞分裂周期 7 (Cdc7) 特异性抑制剂的吡咯并吡啶酮衍生物,并通过 QSAR 和对接方法分析了这些化合物的功效,以深入了解 Cdc7 的相互作用机制和配体选择性。通过回归分析,发现基于网格评分和 Zou-GB/SA 评分的预测模型具有良好的拟合质量(r(2)=0.748, 0.951; r(cv)(2)=0.712, 0.839)。通过测试集验证了模型的准确性,并且使用 Zou-GB/SA 评分的预测值在验证集中的偏差小于使用网格评分的预测值,这表明基于 Zou-GB/SA 评分的模型为预测 Cdc7 抑制剂的效力提供了一种更有效的方法。

相似文献

1
Novel pyrrolopyridinone derivatives as anticancer inhibitors towards Cdc7: QSAR studies based on dockings by solvation score approach.新型吡咯并吡啶酮衍生物作为 Cdc7 的抗癌抑制剂:基于溶剂化能评分方法对接的定量构效关系研究。
Eur J Pharm Sci. 2013 Nov 20;50(3-4):323-34. doi: 10.1016/j.ejps.2013.07.013. Epub 2013 Aug 8.
2
First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.首个细胞周期蛋白依赖性激酶7(Cdc7)抑制剂:作为强效口服活性抗肿瘤药物的吡咯并吡啶酮。2. 先导化合物发现
J Med Chem. 2009 Jan 22;52(2):293-307. doi: 10.1021/jm800977q.
3
Three-dimensional quantitative structure-activity relationships of pyrrolopyridinone as cell division cycle kinase inhibitors by CoMFA and CoMSIA.吡咯并吡啶酮类作为细胞分裂周期蛋白激酶抑制剂的三维定量构效关系:CoMFA 和 CoMSIA 研究。
J Mol Model. 2011 Aug;17(8):2113-30. doi: 10.1007/s00894-011-1016-5. Epub 2011 Mar 18.
4
Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships.细胞周期蛋白依赖性激酶7(Cdc7)抑制剂:吡咯并吡啶酮类作为潜在的抗肿瘤药物。1. 合成及构效关系
J Med Chem. 2008 Feb 14;51(3):487-501. doi: 10.1021/jm700956r. Epub 2008 Jan 18.
5
Cdc7 as a potential new target for cancer therapy.细胞周期蛋白依赖性激酶7(Cdc7)作为癌症治疗的潜在新靶点。
Drug News Perspect. 2008 Nov;21(9):481-8. doi: 10.1358/dnp.2008.21.9.1290818.
6
Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors.三取代噻唑类 Cdc7 激酶抑制剂的合成及构效关系。
Eur J Med Chem. 2014 Jun 10;80:364-82. doi: 10.1016/j.ejmech.2014.04.013. Epub 2014 Apr 5.
7
QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.QSAR 研究咪唑并吡嗪衍生物作为 Aurora A 激酶抑制剂。
SAR QSAR Environ Res. 2012 Oct;23(7-8):705-30. doi: 10.1080/1062936X.2012.719541. Epub 2012 Sep 13.
8
Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.通过片段互补和药物重定位方法鉴定新型 Cdc7 激酶抑制剂作为以 Dbf4 相互作用为靶点的抗癌剂。
EBioMedicine. 2018 Oct;36:241-251. doi: 10.1016/j.ebiom.2018.09.030. Epub 2018 Oct 5.
9
Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.基于 3D-QSAR 和对接方法的咪唑并[4,5-b]吡啶衍生物作为 Aurora A 激酶抑制剂的分子模拟研究。
Eur J Med Chem. 2011 Jan;46(1):77-94. doi: 10.1016/j.ejmech.2010.10.017. Epub 2010 Oct 26.
10
A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.一种Cdc7激酶抑制剂可限制DNA复制的起始并具有抗肿瘤活性。
Nat Chem Biol. 2008 Jun;4(6):357-65. doi: 10.1038/nchembio.90. Epub 2008 May 11.

引用本文的文献

1
Anticancer pyridines induce G2/M arrest and apoptosis via p53 and JNK upregulation in liver and breast cancer cells.抗癌吡啶类化合物通过上调 p53 和 JNK 在肝癌和乳腺癌细胞中诱导 G2/M 期阻滞和细胞凋亡。
Oncol Rep. 2018 Feb;39(2):519-524. doi: 10.3892/or.2017.6116. Epub 2017 Nov 28.
2
Screening of novel inhibitors targeting lactate dehydrogenase A via four molecular docking strategies and dynamics simulations.通过四种分子对接策略和动力学模拟筛选靶向乳酸脱氢酶A的新型抑制剂
J Mol Model. 2015 May;21(5):133. doi: 10.1007/s00894-015-2675-4. Epub 2015 May 2.